Skip to content
healthcare.dev

TERIFLUNOMIDE

NDC 62332-313, TERIFLUNOMIDE, tablet, film coated, from Alembic Pharmaceuticals Inc..

Product NDC
62332-313
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209572
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERIFLUNOMIDE7 mg/1

Pharmacologic classes

Dihydroorotate Dehydrogenase Inhibitors [MoA]; Pyrimidine Synthesis Inhibitor [EPC]

Package NDCNDC-11Package
62332-313-14623320313142 BLISTER PACK in 1 CARTON (62332-313-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK
62332-313-306233203133030 TABLET, FILM COATED in 1 BOTTLE (62332-313-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8c1bc23b-a62b-4172-a603-8b97761514b4
  • NADAC price for package 62332031330

    GET /v1/drugs/nadac/62332031330

Use it

Look up 62332-313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.